|
|
 |
|
Proceedings
Day 3 - Wednesday, September 24, 2003
Recent Regulatory Guidance Bioanalytical Impact on Drug Development
Discussion Leader: Robert P. Clement, Schering Plough Research Institute
Robert P. Clement, Schering Plough Research Institute
Swapan K. Chowdhury, Schering Plough Research Institute
Danielle Lachance, MDS Pharma Services
Roundtable Discussion
Bioanalytical LC/MS/MS Methods: Perspectives and Lessons Learned
Discussion Leader: Min Chang, Abbott Laboratories
Roger Hayes, Schering Plough Research Institute
Yongdong Zhu, Quest Pharmaceutical Services
Patrick Lin, MDS Pharma Services
John D. Laycock, Amgen
Roundtable Discussion
Poster Session Reviews
Discussion Leaders: Alex Buko, Biogen, David S. Wagner, GlaxoSmithKline,
Mingdan Wu, Aventis, and Mingshe Zhu, Bristol-Myers Squibb
Research Informatics in Drug Development
Discussion Leader: John P. Helfrich, NuGenesis Technologies Corporation
John P. Helfrich, NuGenesis Technologies Corporation
Joseph Hofmann, Centocor, Inc.
Kevin Turnbull, Advanced Chemistry Development
Joel Swerdel, Bristol-Myers Squibb
Roundtable Discussion
Vendor/Exhibitor Session
Development Technologies & Applications
Discussion Leaders: Patrick J. Rudewicz, Schering Plough Research Institute
Daniel J. Sudlik, Scientific Software
Paul Corcoran, McKinley Scientific
Gary Impey, Applied Biosystems/MDS Sciex
Joseph J. Mulholland, Thermo Electron Corp.
Victor Fursey, Bruker Daltonics Inc.
Dragan Vuckovic, IONICS Mass Spectrometry Group Inc.
Jeff Jensen, Eksigent Technologies
Luke Roenneburg, Gilson, Inc.
Joseph M. Di Bussolo, Cohesive Technologies, Inc.
Chris Phillips, Nanostream Inc.
Sean Bennett, Waters Corporation
Wrap-Up
Nigel J. Clarke, ActivX Biosciences
|
|